Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Fermion
Fermion
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Containment
Handling potent APIS with care and confidence
Potent active pharma ingredients require ultra careful handling and containment. ChargePoint highlights the challenges and how they were effectively and safely dealt with for contract developer and manufacturer Fermion at Espoo
Manufacturing
Fermion extends its particle engineering capabilities
Ingredients
Smart HPAPI solutions from grams to tons
Fermion’s priority and passion is to offer its clients quick-to-market HPAPI development solutions
Manufacturing
Fermion expands API facility in Hanko, Finland
The Finnish API contract development and manufacturing organisation (CDMO) is expanding its API plant with additional reactor space
You need to be a subscriber to read this article.
Click here
to find out more.
Containment
CDMO strategy key to HPAPI success
As competition grows in highly potent active pharmaceutical ingredients (HPAPI) manufacturing, Arto Toivonen, President of Finnish API manufacturer Fermion, considers key factors that can ensure the successful outsourcing of projects
Subscribe now